0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Diuretics, β-Blockers, and the Risk for Sudden Cardiac Death in Hypertensive Patients

Arno W. Hoes, MD, PhD; Diederick E. Grobbee, MD, PhD; Jacobus Lubsen, MD, PhD; Arie J. Man in 't Veld, MD, PhD; Emiel van der Does, MD, PhD; and Albert Hofman, MD, PhD
[+] Article and Author Information

From Erasmus University Medical School, Rotterdam, the Netherlands. Acknowledgments: The authors thank the municipal authorities in Rotterdam, especially Ronald Lockhorst and his coworkers; Dr. Cremers and his colleagues from the Rotterdam police for their essential contribution to the study; the general practitioners and pharmacists in the Rotterdam area for their enthusiastic support; Margriet Pannevis, PharmD, for obtaining information from the Rotterdam pharmacies; Andrea de Oude-Lubbers, Diane Huizer, Yolanda Bekker, Andrina Cleveringa, Sharmila Bhikha, and Dr. Sjaak Tellekamp for their valuable assistance; Marcel Eijgermans and Dick Tensen for developing the software applications; and Dr. J.P. Vandenbroucke for his helpful comments on the manuscript. Grant Support: By grant 88.145 from the Netherlands Heart Foundation. Requests for Reprints: Arno W. Hoes, MD, PhD, Departments of Epidemiology and Biostatistics and General Practice, Erasmus University Medical School, PO Box 1738, 3000 DR Rotterdam, the Netherlands. Current Author Addresses: Drs. Hoes, Grobbee, and Hofman: Department of Epidemiology and Biostatistics, Erasmus University Medical School, PO Box 1738, 3000 DR Rotterdam, the Netherlands.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1995;123(7):481-487. doi:10.7326/0003-4819-123-7-199510010-00001
Text Size: A A A

Objective: To determine whether the use of non-potassium-sparing diuretics and β-blockers is associated with an excess risk for sudden cardiac death in hypertensive patients.

Design: Case-control study.

Setting: Rotterdam, the Netherlands.

Patients: 257 case-patients who had died suddenly while receiving drug therapy for hypertension and 257 living controls also receiving drug therapy for hypertension.

Measurements: Detailed information on medication use and clinical characteristics of all case-patients and controls was collected from the files of general practitioners. Additional information on medication use was obtained from computerized pharmacy records.

Results: Patients receiving non-potassium-sparing diuretics had an increased risk for sudden cardiac death (relative risk, 1.8 [95% CI, 1.0 to 3.1]) compared with a reference group treated primarily with potassium-sparing diuretics. The corresponding relative risk for β-blocker use was 1.7 (CI, 1.1 to 2.6). The use of non-potassium-sparing diuretics without β-blockers was associated with a higher risk for sudden death (relative risk, 2.2 [CI, 1.1 to 4.6]) than was concomitant use of non-potassium-sparing diuretics and β-blockers (relative risk, 1.4 [CI, 0.6 to 3.0]). The risk for sudden cardiac death among recipients of non-potassium-sparing diuretics was more pronounced in those who had been receiving the diuretic for less than 1 year and in those aged 75 years or younger.

Conclusions: The use of non-potassium-sparing diuretics and β-blockers is associated with an increased risk for sudden cardiac death. This association may offset part of the mortality benefit of these drugs in the treatment of hypertension.

Figures

Grahic Jump Location
Figure 1.
Antihypertensive medication and the risk for sudden cardiac death in patients aged 75 years or younger (n= 242) and those older than age 75 years (n= 272).Table 2

Relative risks and 95% CIs were adjusted for differences in potential confounders by the use of a multivariate statistical model (see ). Bars represent relative risks and 95% CIs. Ref = reference group consisting of patients receiving antihypertensive drugs other than non-potassium-sparing diuretics and β-blockers; N = patients receiving non-potassium-sparing diuretics without β-blockers; B = patients receiving β-blockers without non-potassium-sparing diuretics; N + B = patients receiving non-potassium-sparing diuretics and β-blockers. * = The value of the higher limit of the CI was 16.0.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)